Adar1 Capital Management, LLC Revolution Medicines, Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 170,000 shares of RVMD stock, worth $6.25 Million. This represents 1.49% of its overall portfolio holdings.
Number of Shares
170,000
Previous 44,351
283.31%
Holding current value
$6.25 Million
Previous $2.01 Billion
269.7%
% of portfolio
1.49%
Previous 0.33%
Shares
3 transactions
Others Institutions Holding RVMD
# of Institutions
297Shares Held
168MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$628 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$493 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$487 Million3.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$349 Million0.22% of portfolio
-
Baker Bros. Advisors LP New York, NY7.94MShares$292 Million3.85% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.22B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...